Other
Clinical Pharmacology
0
Pipeline Programs↗
3
Active Trials↗
11
Companies Involved↗
Clinical Pharmacology is an early-stage landscape with 0 programs across 11 companies. The most active players are Tanabe Pharma Corporation, Chiesi Farmaceutici S.p.A., Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
28
clinical trials
Completed25 · 89%
Active, not recruiting2 · 7%
Recruiting1 · 4%
Clinical Trials
Trial Activity
28 trials
Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix
Active, not recruiting·HHan Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair·Phase 1·NCT07182838·20 enrolled
Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
Completed·—·N/A·NCT00823407·12 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)